Aromatase Inhibitor-Associated Musculoskeletal Symptoms #402

被引：0

作者：

Chang, Philip J. ^{[1
]}

机构：

[1] Univ Michigan, Burlington Off Ctr, Dept Phys Med & Rehabil, 325 East Eisenhower Pkwy,Suite 100, Ann Arbor, MI 48104 USA

来源：

JOURNAL OF PALLIATIVE MEDICINE | 2020年 / 23卷 / 11期

关键词：

BREAST-CANCER; POSTMENOPAUSAL WOMEN; INDUCED ARTHRALGIA; TRIAL; THERAPY; TAMOXIFEN; PAIN;

D O I：

10.1089/jpm.2020.0491

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

[No abstract available]

引用

页码：1542 / 1543

页数：2

共 18 条

[1]

[Anonymous], 2019, BREAST CANC FACTS FI

[2] Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer [J].

Cella, David ;

Fallowfield, Lesley ;

Barker, Peter ;

Cuzick, Jack ;

Locker, Gershon ;

Howell, Anthony .

BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (03) :273-284

[3] Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer [J].

Crew, Katherine D. ;

Greenlee, Heather ;

Capodice, Jillian ;

Raptis, George ;

Brafman, Lois ;

Fuentes, Deborah ;

Sierra, Alex ;

Hershman, Dawn L. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) :3877-3883

[4]

Dawn L.Hershman, 2018, JAMA-J AM MED ASSOC, V320, P167

[5] Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer [J].

Gallicchio, Lisa ;

MacDonald, Ryan ;

Helzlsouer, Kathy J. .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (05) :837-843

[6] Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCICCTG MA.17 [J].

Goss, PE ;

Ingle, JN ;

Martino, S ;

Robert, NJ ;

Muss, HB ;

Piccart, MJ ;

Castiglione, M ;

Tu, DS ;

Shepherd, LE ;

Pritchard, KI ;

Livingston, RB ;

Davidson, NE ;

Norton, L ;

Perez, EA ;

Abrams, JS ;

Cameron, DA ;

Palmer, MJ ;

Pater, JL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17) :1262-1271

[7] Randomized, Multicenter, Placebo- Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor- Associated Arthralgias in Early- Stage Breast Cancer: SWOG S1202 [J].

Henry, N. Lynn ;

Unger, Joseph M. ;

Schott, Anne F. ;

Fehrenbacher, Louis ;

Flynn, Patrick J. ;

Prow, Debra M. ;

Sharer, Carl W. ;

Burton, Gary V. ;

Kuzma, Charles S. ;

Moseley, Anna ;

Lew, Danika L. ;

Fisch, Michael J. ;

Moinpour, Carol M. ;

Hershman, Dawn L. ;

Wade, James L., III .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04) :326-+

[8] Randomized Exercise Trial of Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors [J].

Irwin, Melinda L. ;

Cartmel, Brenda ;

Gross, Cary P. ;

Ercolano, Elizabeth ;

Li, Fangyong ;

Yao, Xiaopan ;

Fiellin, Martha ;

Capozza, Scott ;

Rothbard, Marianna ;

Zhou, Yang ;

Harrigan, Maura ;

Sanft, Tara ;

Schmitz, Kathryn ;

Neogi, Tuhina ;

Hershman, Dawn ;

Ligibel, Jennifer .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (10) :1104-1111

[9]

Kubo M, 2012, ANTICANCER RES, V32, P2331

[10] Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data [J].

Lintermans, A. ;

Laenen, A. ;

Van Calster, B. ;

Van Hoydonck, M. ;

Pans, S. ;

Verhaeghe, J. ;

Westhovens, R. ;

Henry, N. L. ;

Wildiers, H. ;

Paridaens, R. ;

Dieudonne, A. S. ;

Leunen, K. ;

Morales, L. ;

Verschueren, K. ;

Timmerman, D. ;

De Smet, L. ;

Vergote, I. ;

Christiaens, M. R. ;

Neven, P. .

ANNALS OF ONCOLOGY, 2013, 24 (02) :350-355

← 1 2 →